Evidence map›Paper›PMID 28953327›Full record

ArticleJournal of the International AIDS Society2017

T cells with low CD2 levels express reduced restriction factors and are preferentially infected in therapy naïve chronic HIV-1 patients.

Sebastian Bolduan, Herwig Koppensteiner, Ramona Businger, Stephanie Rebensburg, Christine Kunze, Ruth Brack-Werner, Rika Draenert, Michael Schindler

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Frontiers in immunology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Sebastian BolduanInstitute of Virology, Helmholtz Zentrum Munich, Munich, Germany.
Herwig KoppensteinerInstitute of Virology, Helmholtz Zentrum Munich, Munich, Germany.
Ramona BusingerInstitute of Medical Virology, University Hospital Tuebingen, Tübingen, Germany.
Stephanie RebensburgInstitute of Virology, Helmholtz Zentrum Munich, Munich, Germany.
Christine KunzeInstitute of Virology, Helmholtz Zentrum Munich, Munich, Germany.
Ruth Brack-WernerInstitute of Virology, Helmholtz Zentrum Munich, Munich, Germany.
Rika DraenertMedizinische Klinik und Poliklinik IV, Section Clinical Infectious Diseases, Klinikum der Universität, Munich, Germany.
Michael SchindlerInstitute of Virology, Helmholtz Zentrum Munich, Munich, Germany.
Helmholtz Zentrum München · DELMU Klinikum · DE

Funding

Else Kröner-Fresenius-Stiftung 2012_A264
6 · The paper itself

Abstract

introductionRestriction factors (RFs) suppress HIV-1 in cell lines and primary cell models. Hence, RFs might be attractive targets for novel antiviral strategies, but their importance for virus control

methodsWe profiled the expression of RFs in primary blood-derived mononuclear cells (PBMC) from therapy-naïve HIV-1 patients and quantified infection.

resultsOverall, there was no correlation between individual RF expression and HIV-1 status in total PBMC. However, we identified a T cell population with low levels of intracellular CD2 and reduced expression of SAMHD1, p21 and SerinC5. CD2

conclusionsIn untreated therapy naïve chronic HIV-1 patients, RF expression in T cells is associated with CD2 expression and seems to influence viral loads. Our study suggests that RFs help to control HIV-1 infection in certain T cells

Indexed as

AdultAgedFemaleHIV-1HIV InfectionsHumansLeukocytes, MononuclearMaleMiddle AgedSAM Domain and HD Domain-Containing Protein 1T-LymphocytesViral LoadSAM Domain and HD Domain-Containing Protein 1SAMHD1 protein, humanHIV-1in vivo relevancep21restriction factorsRISPSAMHD1SerinC5Tetherin

Identifiers

PMID28953327
PMCPMC5964667
OpenAlexW2760775608

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.